封面
市场调查报告书
商品编码
1863220

依药品类型、材料类型、容量范围、瓶盖类型和填充形式分類的医药铝塑管包装市场-全球预测,2025-2032年

Aluminum & Plastic Tube packaging for Pharmaceutical Products Market by Drug Type, Material Type, Volume Range, Closure Type, Filling Form - Global Forecast 2025-2032

出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年,医药铝塑管包装市场规模将达到 122.7 亿美元,复合年增长率为 6.09%。

主要市场统计数据
基准年 2024 76.4亿美元
预计年份:2025年 81.2亿美元
预测年份:2032年 122.7亿美元
复合年增长率 (%) 6.09%

策略性介绍:材料创新、更严格的监管和业务整合重新定义了铝管和塑胶管包装的选择

由于材料科学的进步、监管要求的不断变化以及对供应链韧性日益严格的审查,医药包装行业正处于转折点。铝製和塑胶软管仍然是外用和口腔清洁用品药物的主要包装形式,能够为乳膏、凝胶、软膏和糊剂等製剂提供保护、方便给药和较长的保质期。製造商和品牌所有者的当务之急包括活性成分与软管基材的相容性、耐溶剂性和阻隔性能,以及包装组件的环境生命週期。

永续性的必要性、先进的材料科学和重新构想的筹资策略如何共同改变药品软管包装趋势

三大力量正汇聚,推动该领域发生变革:永续性势在必行、材料和封盖技术的进步,以及由地缘政治摩擦引发的供应链重组。永续性势在必行正在重塑原料的选择和设计概念。製造商正加速测试可回收的单一材料软管以及兼具阻隔性能和废弃物可回收性的混合解决方案。同时,法规结构日益要求提供可回收性声明和清晰的材料成分文件,这使得生命週期评估和第三方检验在供应商选择中发挥了关键作用。

评估关税变化对管状包装供应链韧性、筹资策略和材料采购的系统性影响

2025 年关税环境促使企业重新评估其采购、物流和库存策略,并专注于成本透明度和供应商多元化。关税调整导致某些进口基材和组件的到岸成本上升,推动关键材料的生产转向近岸外包,并重新引起人们对符合监管文件和品质要求的国内加工商的关注。直接的营运影响体现在供应商审核和资格认证流程的重新调整,以降低跨境关税波动带来的风险。

全面的細項分析,将药物类型、材质、容量等级、瓶盖和填充形式与包装性能和操作需求相匹配。

这种富有洞察力的细分为理解需求驱动因素和根据产品及製程要求客製化包装解决方案提供了切实可行的观点。按药品类型划分,非处方药 (OTC) 和处方药之间的差异会影响监管预期、标籤要求以及与活性成分接触的材料所需的技术检验等级。非处方药通常强调成本效益和广泛的分销相容性,而处方药则往往需要更严格的兼容性和可追溯性文件。

影响包装选择的区域市场动态和供应链特征(美洲、欧洲、中东和非洲、亚太地区)

区域趋势影响全球医药包装管市场的筹资策略和产品设计重点。美洲地区强调合规性,采用严格的文檔规范,高度重视可回收性声明,并建立成熟的契约製造伙伴关係,以支持快速规模化生产。北美供应链越来越倾向于选择能够提供快速週转时间和在材料替代和瓶盖创新方面进行技术合作的区域加工商。

在管状包装领域,我们采取竞争与合作并重的企业策略,专注于技术合作、品质保证和永续性措施。

製造商、加工商和特种供应商之间的竞争日益激烈,价值重心正从大宗商品供应转向技术伙伴关係和永续性认证。领先参与企业透过投资阻隔技术、低能耗製造流程以及能够证明产品可回收性和再生材料含量的认证专案来实现差异化竞争。提供技术支援、法规文件和灌装线整合协助等服务的供应商,在与寻求更快上市速度并充满信心的製药客户谈判时,正获得策略优势。

为包装行业领导者提供将永续性融入采购创新并加强供应链韧性和合规性的实用建议

产业领导者应采取整合式方法,在产品开发早期阶段就将采购、研发和法规团队整合起来。这有助于预防相容性问题,并加快认证週期。从处方笺阶段就考虑包装,可以减少返工,并确保封装和基材的选择与所有应用场景相容,从零售店面销售到严格控制的处方笺配药。早期合作也有助于与供应商就共同开发机会和模具共用安排进行更有效的对话,从而缩短前置作业时间并降低整体拥有成本。

我们严谨的研究途径结合了深度访谈、技术审查、供应链分析和生命週期评估,从而提供检验的包装洞察。

本调查方法采用定性和定量相结合的方法,旨在全面、深入地观点当前药品软管包装的现状。主要研究工作包括对包装工程师、法规专家、采购经理和加工商进行结构化访谈,并辅以现场考察和对填充线及模具操作的直接观察。这些第一手资料使得研究人员能够评估各种填充剂型(包括乳膏、凝胶、软膏和糊剂)的材料相容性、瓶盖性能和认证时间。

对技术、监管和供应链方面的必要因素如何塑造具有韧性和可持续性的管状包装策略进行权威、全面的分析。

总之,材料创新、监管要求和供应链重组之间的相互作用正在改变铝管和塑胶管在製药应用中的规格製定、采购和合格。相关人员必须促进跨部门协作,以确保包装选择能够支援产品性能、病患体验和环境目标。对阻隔技术和瓶盖创新进行策略性投资,将有助于产品差异化,同时解决生命週期问题。

目录

第一章:序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 医药包装领域对再生材料製成、低碳足迹铝管的需求激增
  • 扩大高阻隔多层塑胶管在生技药品的应用
  • 将RFID和NFC技术整合到药品包装管中,以增强供应链可追溯性。
  • 在导管内表面开发抗菌聚合物涂层,以延长药物保质期并提高安全性。
  • 监管压力迫使製药企业减少软管包装过程中一次性塑胶的使用。
  • 采用先进的数位印刷技术在铝塑管上製作个人化医疗标籤
  • 轻量化挤出製程创新降低了製药用软管生产的能耗
  • 市场对药品包装管的需求日益增长,这种包装需要设计成儿童难以打开、瓶盖易于老年人使用。
  • 透过医疗领域的管材收集和回收计划,向循环经济模式转型
  • 增加对智慧计量分配器和管状包装的投资,以达到精确计量。

第六章美国关税的累积影响,2025年

第七章:人工智慧的累积影响,2025年

第八章 依药品类型分類的医药铝管和塑胶管包装市场

  • 非处方药
  • 处方药

9. 依材料类型分類的医药铝管和塑胶管包装市场

  • 塑胶

第十章:以销售范围分類的医药铝塑管包装市场

  • 51至100毫升
  • 超过100毫升
  • 50毫升或以下
    • 21至50毫升
    • 20毫升或以下

第十一章 以瓶盖类型分類的医药铝塑管包装市场

  • 翻盖
  • 螺帽
  • 卡扣式帽

第十二章 依灌装类型分類的医药铝管和塑胶管包装市场

  • 奶油
  • 凝胶
  • 软膏
  • 贴上

第十三章:依地区分類的医药铝塑管包装市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 医药铝塑管包装市场(依组别划分)

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章:各国医药铝塑管包装市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵,2024
  • 竞争分析
    • Amcor plc
    • Berry Global Group, Inc.
    • Silgan Holdings Inc.
    • AptarGroup, Inc.
    • Essentra plc
    • CCL Industries Inc.
    • Albea SA
    • Tekni-Plex, Inc.
    • Gerresheimer AG
Product Code: MRR-A0184B3CF206

The Aluminum & Plastic Tube packaging for Pharmaceutical Products Market is projected to grow by USD 12.27 billion at a CAGR of 6.09% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 7.64 billion
Estimated Year [2025] USD 8.12 billion
Forecast Year [2032] USD 12.27 billion
CAGR (%) 6.09%

A strategic introduction framing how material innovation, regulatory rigor, and operational integration are redefining aluminum and plastic tube packaging choices

The pharmaceutical packaging landscape has reached an inflection point driven by material science advances, evolving regulatory expectations, and heightened scrutiny of supply-chain resilience. Aluminum and plastic tubes remain core delivery formats for topical and oral care pharmaceuticals, offering protection, dosing convenience, and extended shelf life for cream, gel, ointment, and paste formulations. Near-term priorities for manufacturers and brand owners include compatibility of active ingredients with tube substrates, solvent and barrier performance, and the environmental lifecycle of packaging components.

Recent product innovation has emphasized not only barrier integrity and dosing accuracy but also secondary attributes such as printability for lot and regulatory information, tactile experience for patient adherence, and compatibility with automated filling lines. These operational considerations intersect with sustainability targets as firms reassess single-use plastics, aluminum reclamation pathways, and the viability of mono-material constructions. Consequently, procurement, R&D, and regulatory affairs teams are increasingly collaborating to align packaging specifications with clinical and commercial product strategies.

Transitioning from traditional sourcing practices, stakeholders now seek closer integration with converters and material suppliers to accelerate qualification of alternative substrates and closures. The result is a more iterative development cycle in which early-stage packaging decisions are treated as substantive contributors to product performance and cost to serve. This introduction frames the critical trade-offs and decision axes that companies must navigate today to ensure product integrity, regulatory compliance, and market competitiveness.

How sustainability imperatives, advanced material science, and reshaped sourcing strategies are jointly transforming pharmaceutical tube packaging dynamics

The sector is experiencing transformative shifts driven by three converging forces: sustainability mandates, technological advancements in materials and closures, and supply-chain realignment prompted by geopolitical friction. Sustainability mandates are reshaping raw-material choices and design philosophy. Manufacturers are accelerating trials of recyclable mono-material tubes and hybrid solutions that balance barrier performance with end-of-life recovery. Meanwhile, regulatory frameworks increasingly expect clear documentation of recyclability claims and material composition, which has elevated the role of lifecycle assessments and third-party verification in supplier selection.

Material science has delivered notable improvements in multilayer extrusion and barrier coatings that permit thinner walls and reduced material weight while preserving protection for sensitive formulations. Closures have evolved beyond simple mechanical seals to incorporate precision dispensing and child-resistant functionality where required, supported by tighter tolerances and higher fill-line accuracy on modern filling lines. These innovations reduce product waste and improve patient experience, but they also demand updated qualification protocols and closer collaboration between formulators and packaging engineers.

Supply-chain realignment has altered sourcing strategies. Companies are balancing cost pressures with a desire for redundancy by developing regional supplier relationships, qualified alternate converters, and inventory-buffer strategies that mitigate single-source risks. This shift encourages longer-term commercial agreements and joint investment in capacity or tooling shared across product portfolios. As stakeholders adapt, decision-making increasingly favors partners capable of offering technical support, regulatory documentation, and demonstrable sustainability credentials alongside competitive lead times.

Assessing the systemic consequences of tariff shifts on supply-chain resilience, procurement strategy, and material sourcing for tube packaging

The tariff landscape introduced in 2025 has led companies to re-evaluate procurement, logistics, and inventory strategies with an emphasis on cost transparency and supplier diversification. Tariff-related adjustments have increased landed costs for certain imported substrates and components, prompting a shift toward nearshoring for critical inputs and a renewed focus on domestic converters capable of meeting regulatory documentation and quality expectations. The immediate operational consequence has been a re-prioritization of supplier audits and qualification pipelines to reduce exposure to cross-border tariff volatility.

In response, manufacturers have intensified efforts to validate alternative materials and to renegotiate commercial terms that absorb some tariff-induced cost increases. The dynamic has also accelerated investment in inventory optimization and demand-smoothing mechanisms to avoid production interruptions tied to import delays. Moreover, the tariff environment has amplified the importance of robust cost-engineering practices, pushing packaging and procurement teams to identify design efficiencies and to collaborate on tool standardization that can lower unit conversion costs over time.

Regulatory compliance and customs classification have taken on greater strategic significance, as proper tariff classifications and documentation can materially affect landed costs and clearance times. Consequently, legal and compliance functions have become more involved in packaging sourcing decisions, ensuring that material specifications, country-of-origin declarations, and preferential trade program eligibility are fully assessed. Overall, the tariff developments have reshaped risk assessment frameworks, steering the industry toward more diversified supply footprints, closer supplier partnerships, and a disciplined focus on total cost of ownership rather than purely unit price.

Comprehensive segmentation insights that align drug types, materials, volume classes, closures, and filling forms with packaging performance and operational needs

Insightful segmentation provides a practical lens for understanding demand drivers and tailoring packaging solutions to product and process requirements. When examined by drug type, distinctions between over-the-counter formulations and prescription products influence regulatory expectations, labeling requirements, and often the level of technical verification demanded for materials in contact with actives. Over-the-counter products commonly emphasize cost efficiency and broad distribution compatibility, whereas prescription drugs frequently require more rigorous documentation of compatibility and traceability.

Material type segmentation highlights a fundamental trade-off between aluminum and plastic substrates. Aluminum offers established barrier performance and recyclability pathways, particularly suited to sensitive formulations and high-barrier requirements, while plastic variants enable economical, lightweight constructions and compatibility with diverse closure systems. Volume range segmentation reveals that tubes sized 51 to 100 milliliter and above 100 milliliter serve different channel and dosing requirements compared with smaller formats. Up to 50 milliliter tubes, especially those in 21 to 50 milliliter or up to 20 milliliter subranges, are tailored for portability, sample distribution, and patient adherence, and thus often prioritize tactile design, tamper evidence, and compatibility with smaller-scale filling systems.

Closure type segmentation identifies important interface considerations between container and user, with flip top, screw cap, and snap cap options delivering distinct user experiences, re-seal performance, and fill-line compatibility. Flip top closures support single-handed dispensing and everyday convenience, screw caps offer robust sealing for longer-term storage, and snap caps provide cost-effective sealing with rapid access for frequent use. Filling form segmentation-covering cream, gel, ointment, and paste-dictates substrate selection, wall thickness, and closure design due to differences in viscosity, shear sensitivity, and interaction with inner coatings. Taken together, these segmentation dimensions inform design optimization, supplier selection, and quality assurance protocols to ensure alignment between product characteristics and packaging performance.

Regional market dynamics and supply-chain attributes across the Americas, Europe Middle East & Africa, and Asia-Pacific that influence packaging choices

Regional dynamics shape both sourcing strategies and product design priorities across the global footprint of pharmaceutical tube packaging. The Americas region emphasizes regulatory compliance with stringent documentation practices, strong emphasis on recyclability claims, and maturity in contract manufacturing partnerships that support rapid scale-up. North American supply chains display a growing preference for regional converters that can provide quick turnarounds and technical collaboration on material substitution and closure innovation.

The Europe, Middle East & Africa region combines high regulatory rigor with advanced circular-economy initiatives that drive adoption of certified recycling streams and mono-material designs. European regulators and industry bodies have accelerated requirements for accurate recyclability communication, which in turn pushes suppliers to prioritize validated recovery solutions and low-impact material choices. Meanwhile, the Middle East and Africa present opportunities for capacity expansion and localized packaging solutions that address climatic considerations and channel-specific distribution challenges.

Asia-Pacific remains a center of manufacturing scale and rapid innovation, balancing cost competitiveness with increasing attention to sustainability and compliance. The region hosts a broad spectrum of converters capable of high-volume production and sophisticated multilayer extrusion, while also seeing growth in regionally focused suppliers that offer rapid prototyping and tooling services. Across all regions, effective market participation depends on aligning supplier capabilities with regional regulatory expectations, environmental initiatives, and the specific channel requirements of formulators and brand owners.

Competitive and collaborative company strategies emphasizing technical partnerships, quality assurance, and sustainability credentials in tube packaging

Competitive dynamics among manufacturers, converters, and specialty suppliers are intensifying as value shifts from commodity supply toward technical partnership and sustainability credentials. Key players differentiate through investments in barrier technologies, low-energy manufacturing processes, and certification programs that validate recyclability or recycled content. Service-oriented providers that bundle technical support, regulatory documentation, and fill-line integration assistance command a strategic advantage in conversations with pharmaceutical clients looking to accelerate time-to-market with confidence.

Collaborative innovation models have become more common, with formulators co-developing materials and closures to solve specific compatibility challenges or to reduce environmental impact. Strategic alliances, joint ventures, and co-investments in tooling and pilot capacity enable faster qualification of new substrates and permit shared risk across multiple product launches. At the same time, smaller specialty converters are carving niches by offering bespoke formulations for inner coatings, rapid prototyping, and agility in low-to-medium volume production runs that larger plants may not economically support.

Quality systems, supply continuity assurances, and traceability capabilities are decisive selection criteria for clients in regulated markets. Suppliers that provide robust documentation packages-covering material origin, compatibility testing, and batch traceability-are positioned to win long-term contracts. In addition, firms that can demonstrate continuous improvement in energy use, waste reduction, and circular design principles strengthen their competitive proposition as brand owners push sustainability agendas across their entire product portfolios.

Actionable recommendations for packaging leaders to align procurement, innovation, and sustainability while strengthening supply-chain resilience and compliance

Industry leaders should pursue an integrated approach that aligns procurement, R&D, and regulatory teams early in product development to preempt compatibility issues and accelerate qualification cycles. Embedding packaging considerations into formulary decisions will reduce rework and ensure that closure and substrate choices complement the intended use case, whether for retail over-the-counter distribution or tightly controlled prescription dispensing. Early alignment also enables more effective dialogue with suppliers on co-development opportunities and tool-sharing arrangements that can reduce lead times and total cost of ownership.

Leaders should prioritize supplier diversification and regional qualification to insulate operations from tariff exposure and logistic disruptions. Establishing a primary and secondary supplier footprint with cross-qualified tooling or validated alternative materials will enhance resilience without sacrificing product integrity. Concurrently, investing in barrier technology trials and lifecycle assessments will help identify opportunities to transition to mono-material constructions or to incorporate higher recycled content while maintaining compatibility with creams, gels, ointments, and pastes.

Finally, companies must elevate documentation and traceability as core capabilities. Comprehensive material data packages, compatibility evidence, and clear recyclability claims not only support regulatory compliance but also strengthen commercial positioning with sustainability-focused customers. By coupling these internal initiatives with strategic partnerships for pilot production, testing, and certification, industry leaders can accelerate innovation, reduce risk, and create demonstrable value for stakeholders across the supply chain.

A rigorous research approach combining primary interviews, technical review, supply-chain mapping, and lifecycle assessment to produce validated packaging insights

The research methodology combines qualitative and quantitative techniques to ensure a robust, multi-faceted understanding of the pharmaceutical tube packaging landscape. Primary research consisted of structured interviews with packaging engineers, regulatory specialists, procurement leaders, and converters, complemented by site visits and direct observation of filling lines and tooling operations. These firsthand insights informed assessments of material compatibility, closure performance, and qualification timelines across different filling forms such as cream, gel, ointment, and paste.

Secondary research integrated technical literature, patent filings, trade data, and regulatory guidance to map material innovations, barrier technologies, and certification programs. Comparative analysis of manufacturing processes, from aluminum drawing and annealing to plastic extrusion and lamination, provided context for quality control practices and potential failure modes. The methodology also included lifecycle and recyclability assessments using established environmental frameworks to evaluate end-of-life considerations for aluminum and plastic constructions.

Data validation occurred through triangulation across sources and iterative expert review, ensuring that findings reflect current operational realities and emerging trends. Expert panels provided feedback loops to refine conclusions and to prioritize recommendations. Together, these approaches produced a comprehensive, evidence-based picture of technological trajectories, supplier capabilities, and the practical trade-offs that manufacturers face when selecting tube formats and closure systems for regulated pharmaceutical applications.

A conclusive synthesis of how technical, regulatory, and supply-chain imperatives are shaping resilient and sustainable tube packaging strategies

In conclusion, the interplay of material innovation, regulatory expectations, and supply-chain realignment is redefining how aluminum and plastic tubes are specified, sourced, and qualified for pharmaceutical use. Stakeholders must embrace cross-functional collaboration to ensure that packaging choices support product performance, patient experience, and environmental objectives. Strategic investment in barrier technologies and closure innovations will enable product differentiation while addressing lifecycle concerns.

At the same time, evolving trade dynamics and tariff considerations have underscored the need for diversified supplier networks and meticulous documentation to sustain production continuity. Firms that proactively incorporate sustainability metrics, robust traceability, and supplier qualification strategies into their packaging programs will be better positioned to manage risk and to meet the evolving expectations of regulators and end customers. The path forward favors organizations that combine technical rigor with agile procurement and collaborative supplier relationships to deliver safe, compliant, and sustainable packaging solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Surge in demand for aluminum tubes with recycled content and low carbon footprint in pharmaceutical packaging
  • 5.2. Growing adoption of multilayer plastic tubes with high barrier performance for biologic drug formulations
  • 5.3. Integration of RFID and NFC technology into pharmaceutical tubes for enhanced supply chain traceability
  • 5.4. Development of antimicrobial polymer coatings on tube interiors to extend drug shelf life and safety
  • 5.5. Regulatory pressure driving pharma manufacturers to reduce single-use plastic in tube packaging operations
  • 5.6. Emergence of advanced digital printing on aluminum and plastic tubes for personalized medicine labels
  • 5.7. Innovation in lightweight extrusion processes reducing energy consumption in pharma tube production
  • 5.8. Rising need for child-resistant and senior-friendly closure designs in pharmaceutical tube packaging
  • 5.9. Shift towards circular economy models with tube take-back recycling programs in the healthcare sector
  • 5.10. Increased investment in smart metering dispensers integrated with tube packaging for precise dosing

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Drug Type

  • 8.1. OTC
  • 8.2. Prescription Drugs

9. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Material Type

  • 9.1. Aluminum
  • 9.2. Plastic

10. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Volume Range

  • 10.1. 51 To 100 Milliliter
  • 10.2. Above 100 Milliliter
  • 10.3. Up To 50 Milliliter
    • 10.3.1. 21 To 50 Milliliter
    • 10.3.2. Up To 20 Milliliter

11. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Closure Type

  • 11.1. Flip Top
  • 11.2. Screw Cap
  • 11.3. Snap Cap

12. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Filling Form

  • 12.1. Cream
  • 12.2. Gel
  • 12.3. Ointment
  • 12.4. Paste

13. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Aluminum & Plastic Tube packaging for Pharmaceutical Products Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Amcor plc
    • 16.3.2. Berry Global Group, Inc.
    • 16.3.3. Silgan Holdings Inc.
    • 16.3.4. AptarGroup, Inc.
    • 16.3.5. Essentra plc
    • 16.3.6. CCL Industries Inc.
    • 16.3.7. Albea S.A.
    • 16.3.8. Tekni-Plex, Inc.
    • 16.3.9. Gerresheimer AG

LIST OF FIGURES

  • FIGURE 1. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OTC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OTC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OTC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OTC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OTC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OTC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ALUMINUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 51 TO 100 MILLILITER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 51 TO 100 MILLILITER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 51 TO 100 MILLILITER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 51 TO 100 MILLILITER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 51 TO 100 MILLILITER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 51 TO 100 MILLILITER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABOVE 100 MILLILITER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABOVE 100 MILLILITER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABOVE 100 MILLILITER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABOVE 100 MILLILITER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABOVE 100 MILLILITER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY ABOVE 100 MILLILITER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 21 TO 50 MILLILITER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 21 TO 50 MILLILITER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 21 TO 50 MILLILITER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 21 TO 50 MILLILITER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 21 TO 50 MILLILITER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY 21 TO 50 MILLILITER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 20 MILLILITER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 20 MILLILITER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 20 MILLILITER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 20 MILLILITER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 20 MILLILITER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 20 MILLILITER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FLIP TOP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FLIP TOP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FLIP TOP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FLIP TOP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FLIP TOP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FLIP TOP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SCREW CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SCREW CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SCREW CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SCREW CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SCREW CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SNAP CAP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SNAP CAP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SNAP CAP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SNAP CAP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SNAP CAP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CREAM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CREAM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CREAM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CREAM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CREAM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OINTMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OINTMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OINTMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OINTMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY OINTMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PASTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PASTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PASTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PASTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PASTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY PASTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2025-2032 (USD MILLION)
  • TABLE 209. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY VOLUME RANGE, 2025-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2018-2024 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY UP TO 50 MILLILITER, 2025-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY CLOSURE TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY FILLING FORM, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY DRUG TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN ALUMINUM & PLASTIC TUBE PACKAGING FOR PHARMACEUTICAL PRODUCTS MARKET SIZE, BY MATERIAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN ALUMI